We’re proud to share that our Head of R&D, Nikolaos Nikolaou has been selected to give an oral presentation at the upcoming EMBO Workshop: Liver and Pancreas in Metabolic Disease.
Nik's presentation is titled: iPSC-derived hepatocytes accurately recapitulate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in vitro, offering a novel platform for large-scale drug efficacy screening studies. He will be delivering it on 2nd April at 12.50pm CEST
